NEPHROLOGY 2007; 12, 3–7 doi:10.1111/j.1440-1797.2006.00748.x Original Article Factors associated with metabolic acidosis in patients receiving parenteral nutrition I-CHIEH TSAI,1 JENQ-WEN HUANG,2 TZONG-SHINN CHU,2 KWAN-DUN WU2 and TUN-JUN TSAI2 1Department of Internal Medicine, Taipei Hospital, Department of Health, Hsin-Chuang City and 2National Taiwan University Hospital, Taipei, Taiwan SUMMARY: Aims: Metabolic acidosis is a common problem after infusion with chloride-based parenteral nutrition. However, it is unknown whether the occurrence of metabolic acidosis is related to this regimen of therapy or to patient- specific risk factors. Methods: Patients receiving parenteral nutrition from July to December 2003 at this hospital were included for a retrospective study. Patients were excluded who had illnesses that were potentially related to acid-base disorders. The remaining patients were divided on the basis of parental nutrition they had received: a chloride- base regimen group, and an acetate-based therapy group. Biochemical character and blood gas data were analysed. Continuous variables were analysed by t-test. Categorical variables were assessed by chi-squared test. Independent determinants for bicarbonate decline were analysed using forward stepwise multiple linear regression analysis. Results: There were 29 patients (17 women, 12 men) who received chloride-based regimen and 26 patients (16 women, 10 men) took acetate-based therapy. The acetate group had significantly higher baseline serum creatinine and blood urea nitrogen than chloride group. The blood pH, CO2, bicarbonate and base excess were significantly lower after receiving chloride-based therapy; while these changes were not observed in acetate- based therapy group. However, the serum creatinine and blood urea nitrogen levels were not statistically different. With multiple-stepwise linear regression, parenteral nutrition formula and estimated creatinine clearance are independent predictors of bicarbonate decline. Conclusion: The acetate-base regimen can decrease the occurrence of metabolic acidosis after parenteral nutrition. In addition, the risk of acidosis is higher in patients with impaired renal function. KEY WORDS: acetate, chloride, creatinine, metabolic acidosis, parenteral nutrition. Metabolic acidosis can occur in patients receiving additional chloride ions for pH adjustment had also been parenteral nutrition via both underlying disease and in the discussed in rabbits4 and preterm neonates.5 composition of the nutritional solutions.1 Acidosis caused We observed an increase in the incidence of metabolic by parenteral nutrition is related to (i) interruption of meta- acidosis after introducing a new chloride-based parenteral bolic pathway of carbohydrate and fat; (ii) metabolism of nutrition formula (Aminomix 1) to this hospital. Sodium cationic amino acids2 and sulphur-containing amino acids;3 bicarbonate and even more haemodialysis were required to (iii) the titratable acidity of solutions, although this factor is treat the acidosis. However, these therapeutic effects were not favoured by most authors;2 (iv) deficiency of thiamine or transitory and metabolic acidosis quickly returned. As we biotin; and (v) injection of D-fructose. Besides, the changed the formula to an acetate-based regimen (Paren- aid), the serum bicarbonate level elevated. The most differ- ent composition of these two formulas is the concentration Correspondence: Associate Professor Tzong-Shinn Chu, Depart- ratio of acetate and chloride. (Table 1) The purpose of the ment of Internal Medicine, National Taiwan University Hospital. No. present study was to identify whether metabolic acidosis was 7, Chung-Shan South Road, Taipei 100, Taiwan. Email: significantly related to the regimen of therapy. In addition, [email protected] we analysed the roles of other clinical and biochemical Accepted for publication 9 October 2006. variables in order to determine if certain risk factors exist in © 2007 The Authors the occurrence of metabolic acidosis during administration Journal compilation © 2007 Asian Pacific Society of Nephrology of parenteral nutrition. 4 I-C Tsai et al. Table 1 Composition of parenteral nutrition solutions Paren-aid No. 2 Paren-aid No. 3 Aminomix 1 Electrolyte (mEq/L) Na 30 30.4 50 K303030 Ca – 20 5 Mg 8 8 5 Cl 30.4 33 100.11 Phosphate 12.5 – 15 Acetate 17.5 30 – Zn – – 0.08 Glucose (g/L) 250 250 200 Amino acid (g/L) – – 50 kCal/L 1000 1000 1025 mOsm/L 1518 1550 1769 pH 4.5–6 4.5–6 4.8–5.2 METHODS other patients with high anion gap metabolic acidosis or mixed high anion gap metabolic acidosis/metabolic alkalosis We performed a retrospective analysis on the records of patients receiv- were also excluded. In addition, six patients with hypercap- ing parenteral nutrition in our hospital for more than 10 days during nia respiratory acidosis (CO2 > 44 mmHg) were excluded. the 6-month period, July 2003 to December 2003. Patients who had The remaining 55 patients were divided into two groups. one of the following conditions after parenteral nutrition, which could Group I included 29 patients who had received chloride- result in an acid-base disorder were excluded: (i) severe diarrhea; based (Aminomix 1) parenteral nutrition and group II (ii) pure high anion gap metabolic acidosis; (iii) mixed high anion gap metabolic acidosis and metabolic alkalosis; and (iv) included 26 patients who had received acetate-based (Paren-aid) regimen. As shown in Table 1, the acetate- PaCO2 > 44 mmHg. based solution did not contain amino acids. For this reason, patients in this group received additional amino acid solu- Definitions tions, and the compositions of them were displayed in Table 2. Ten patients took amino 12X, 13 patients took The anion gap was calculated by using the equation: [Na+] - – – aminoleban, and three patients received moriamin-SN ([Cl ] + [HCO3 ]). This value was adjusted downward as reduction in solutions. the anion gap of 2.5 meq/L for every 1 g/dL declined from 4 g/dL in the serum albumin concentration. A mixed metabolic disorder was – Clinical characteristics at the beginning of therapy detected by use of the following ratio: Danion gap/Dplasma HCO3 6 concentration. Analyses of the demographic data comparing the two groups After excluding patients with (i) severe diarrhea; (ii) pure high of patients found no statistical differences in age, sex distri- anion gap metabolic acidosis; (iii) mixed high anion gap metabolic bution, or estimated creatinine clearance between the acidosis and metabolic alkalosis; and (iv) PaCO2 > 44 mmHg; we – 7 groups. However, statistical analyses found that group II defined metabolic acidosis as HCO3 smaller than 22 meg/L. Estimated creatinine clearance was calculated via Cockcroft- patients had a statistically significant higher baseline serum Gault equations as follows: ClCr(ml/min) = [(140 - age) ¥ BW(kg)]/ creatinine, blood urea nitrogen level than group I (Table 3). [72 ¥ serum Cr (mg/dL)] ¥ 0.85 (for women)8 Biochemical status after receiving parenteral nutrition Statistical analysis Patients with chloride-based formula had significantly lower pH, CO2, bicarbonate, and base excess than the acetate- The statistical program SPSS was used to analyse sample data. Descrip- based formula group after receiving parenteral nutrition. 1 tive analyses are reported as means SD unless otherwise specified. Chloride and sodium levels were higher in the chloride- The t-test was used to analyse continuous variables, while categorical based formula group. However, the serum creatinine and variables were assessed by the chi-squared test. A P-value of less than 0.05 was considered statistically significant. Linear regression analysis blood urea nitrogen levels were not different statistically was used to find predictive variables for the occurrence of fall in bicar- between these two groups of patients (Table 3). The inci- bonate level after parenteral nutrition. dence of metabolic acidosis was significant higher in chloride-based group (Table 4). RESULTS In patients with renal function impairment There were 68 patients initially recruited into this study. We classified patients according to pretreatment estimated Four patients were excluded for severe diarrhea, and three CCr into two groups; estimated CCr larger than 30 mL/min © 2007 The Authors Journal compilation © 2007 Asian Pacific Society of Nephrology Acidosis in parenteral nutrition 5 Table 2 Composition of amino acid solutions Components Amino 12X Aminoleban Moriamin-SN Aminomix 1 Amino acids (g/L) L-Isoleucine 5.97 9 5.6 2.5 L-Leucine 11.38 11 12.5 3.7 L-Lysine HCl 9.80 7.6 4.125 L-Lysine Acetate 12.4 L-Methionine 4.33 1 3.5 2.15 L-Phenylalanine 9.74 1 9.35 2.55 L-Tryptophan 1.87 0.7 1.3 1 L-Threonine 5.04 4.5 6.5 2.2 L-Valine 6.90 8.4 4.5 3.1 L-Cysteine 0.23 0.3 1 L-Tyrosine 0.57 0.35 L-Arginine HCL 14.88 7.3 7.9 6 L-Histidine HCl 7.06 3.2 6 1.5 L-Alanine 8.21 7.5 6.2 7.5 L-Aspartic Acid 2.02 3.8 L-Glutamic Acid 1.02 6.5 L-Proline 10.63 8 3.3 7.5 L-Serine 4.67 5 2.2 Glycine 15.68 7 Xylitol 50.00 L-Malic acid 3.065 Electrolyte (mEq/L) Na 150 14 <550 Cl 150 94 0 100.11 Acetate 0 0 60 0 pH 5.0–7.0 5.5–6.5 5.5–6.5 4.8–5.2 Table 3 Laboratory data before and after parenteral nutrition Group I (Aminomix 1) Group II (Paren-aid) Before Infusion After Infusion Before Infusion After Infusion Mean 1 SD Mean 1 SD Mean 1 SD Mean 1 SD Age 67.45 1 13.89 64.46 1 14.22 Sex (M : F) 17:12 16:10 Estimated CCr (ml/min) 41.06 1 23.66 – 35.89 1 25.10 – pH 7.44 1 0.07††† 7.36 1 0.08*** 7.45 1 0.05 7.43 1 0.05 CO2 (mmHg) 32.50